Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 59.77 USD -0.5% Market Closed
Market Cap: 3.7B USD
Have any thoughts about
Rhythm Pharmaceuticals Inc?
Write Note

Rhythm Pharmaceuticals Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rhythm Pharmaceuticals Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Net Change in Cash
$46.1m
CAGR 3-Years
23%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
-$6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$669m
CAGR 3-Years
57%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$25.7B
CAGR 3-Years
N/A
CAGR 5-Years
-116%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$148.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Rhythm Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
46.1m USD

Based on the financial report for Sep 30, 2024, Rhythm Pharmaceuticals Inc's Net Change in Cash amounts to 46.1m USD.

What is Rhythm Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
28%

The average annual Net Change in Cash growth rates for Rhythm Pharmaceuticals Inc have been 23% over the past three years , 28% over the past five years .

Back to Top